A Medical Device Daily
St. Jude Medical (St. Paul, Minnesota), reported that Eric Fain will become president of its Cardiac Rhythm Management Division (CRMD), effective July 1, succeeding Michael Coyle, who will transition out of this role after 13 years with the company.
Fain has been with St. Jude companies for 20 years, most recently as executive VP for development and clinical/regulatory affairs for CRMD, the company's largest division.
"Eric Fain is a 20-year veteran of the ICD business, who has played an integral role in the success of our cardiac rhythm management division," said Daniel Starks, president/CEO and chairman of St. Jude. "His clinical, regulatory and product development experience and knowledge make him ideally suited to lead this group."
Fain has been responsible for managing all implantable cardioverter defibrillator (ICD), pacemaker and related technology development; U.S. and international regulatory submissions; U.S. and international clinical studies; and the U.S. field clinical engineering and technical support organizations for CRMD.
He joined Ventritex (now part of St. Jude Medical) in 1987 and was named CRMD's senior VP, clinical engineering and regulatory affairs in 1998. In 2002, his role was broadened to include product development responsibilities, and in 2005 he was promoted to his current position.
Coyle joined St. Jude in 1994 as director of business development. In 1997, he was named president of St. Jude Medical's daig division.